Introduction
============

Microbial sources like actinomycetes are well recognized to produce a variety of chemical structures, several of which are most valuable pharmaceuticals, agrochemicals and industrial products like enzymes ([@B49]). Actinomycetes are considered to be preferred enzymes sources due to their production of extracellular enzymes. Many enzymes produced by actinomycetes and have been used as drugs like wise L-glutamine amidohydrolase (E.C. 3.5.1.2), commonly referred to as L-glutaminase ([@B45]). Since the discovery of its anti-tumor properties, L-glutaminases have been in prime focus ([@B24]). Nowadays, L-glutaminase is used as enzyme therapy for cancer especially for acute lymphocytic leukemia ([@B36]; [@B21]).

Where, high rate of glutamine consumption is a characteristic nature of some types of cancerous cells ([@B24]). Based on this character experimental therapies have been developed to deprive L-glutamine to tumor cells ([@B14]). Inhibition of the tumor cell uptake of glutamine is one of the possible ways to stop the growth and this is the best accomplished by the use of L-glutaminase. This in fact, results in a selective starvation of the tumor cells because unlike normal cells lack properly functioning glutamine biosynthetic machinery ([@B47]; [@B8]). Microbial therapeutic enzymes have a broad variety of specific uses as oncolytics, thrombolytics or anticoagulant, and largely as anticancer ([@B39]; [@B41]).

The production of enzyme was influenced by a variety of physicochemical and nutritional factors. The factors affecting the production in recent years had received attention as of its great demand in clinical application and also in food industries. It is known that, the factors involved in the process of production, would not only enhance the quantity, but also quality of enzyme because of which it becomes more suitable for a specific application. Optimization of parameters can in turn influence enzyme synthesis and cell yield ([@B31]). The strain of actinomycetes was used for glutamic acid production under optimum growth conditions ([@B10]). From the compatibility perspective in mass production and as well as beneficial application aspect extracellular enzyme producer as choice of source is always attractive ([@B32]). The objective of this study was to utilize *Streptomyces canarius* FR with good ability to produce extracellular L-glutaminase and characterize the purification. Biochemical, kinetics and *in vitro* anticarcenogenic properties of L-glutaminase will be also examined.

Materials and Methods
=====================

Collection, isolation and identification of S. canarius FR
----------------------------------------------------------

*Streptomyces canarius* FR isolated from Tell Basta, Zagazig, Sharkyia Governorate, Egypt was identified according to identification keys ([@B15]). The identification was confirmed by the analysis of 16S rRNA gene sequence ([@B1]).

The strain was preliminary tested for L-glutaminase production by streaking on minimal glutamine agar medium (MGA) plates. Components of MGA (g/L) include: KCl 0.5; MgSO~4~7H~2~O 0.5; KH~2~PO~4~ 1.0; FeSO~4~7H~2~O 0.1; ZnSO~4~7H~2~O 1.0; glutamine 5 and phenol red 0.012. The plates were incubated at 30 °C for 5 days. Formation of pink zones around the microbial growth indicated the positive reaction ([@B4]; [@B3]).

Optimization of culture conditions for L-glutaminase production
---------------------------------------------------------------

*Streptomyces canarius* FR was cultivated in L-glutaminase production modified Czapek\'s medium contained (g/L): L-glutamine 10; D-glucose 5; MgSO~4~7H~2~O 0.5; KCl 0.05; KH~2~PO~4~ 1.0. Enzyme production was tested under different cultured conditions; different incubation periods (0-8 days); different temperatures (25-55 °C); different pH-values (pH 4-10) under shaking and static conditions. The culture was harvested and centrifuged at 10,000 rpm for 30 min the obtained cell free filtrate was used as crude enzyme according to [@B11].

Activity assay and Protein determination of L-glutaminase
---------------------------------------------------------

The activity of glutaminase enzyme is determined by estimating the amount of NH3 liberated from glutamine ([@B7]). Protein concentration was determined by [@B26] using bovine serum albumin (Sigma chemical Co.) as a standard.

L- Glutaminase purification
---------------------------

Two liters from the nutritionally optimized submerged 5 days culture of *S. canarius* FR growing in L-Reda glutaminase producing medium was prepared. The precipitated protein was collected by centrifugation at 10,000 rpm at 4 °C and dissolved in a minimum volume of phosphate buffer (0.01 M, pH 8.0) ([@B41]). L-glutaminase was fractionated by salting out (50-80% ammonium sulphate saturation). The collected precipitate was dissolved in phosphate buffer (0.01 M, pH 8.0) and then dialyzed against the same buffer for 24 h at 4 °C with continuous stirring and occasional changes of the buffers. The dialyzate was fractionated by ion-exchange chromatography (DEAE-Cellulose). After column equilibration the enzyme was eluted by gradient NaCl (50-200 mM) dissolved in phosphate buffer (0.1 M, pH 8.0) with 0.001 M EDTA. The activity, homogeneity (SDS-PAGE) and protein contents of the fractions were determined as above. The most active homogenous fractions were gathered and loaded to pre-equilibrated column of Sephadex G100 gel-filtration chromatography) using the same buffer for elution. For each fraction activity was assessed as above. The most active fractions were pooled and concentrated by dialysis against buffer ([@B28]).

SDS-PAGE Analysis
-----------------

The molecular weight of L-glutaminase from culture of *S. canarius* was carried out using SDS-PAGE according to [@B22]. PageRuler Unstained Protein Ladder, Fermentas marker was used.

Biochemical and kinetic properties of the purified L-glutaminase
----------------------------------------------------------------

The biochemical properties of purified *S. canarius* L-glutaminase as optimum pH, pH stability, reaction temperature, thermal stability salt tolerance, metal ions and substrate specificity enzyme were determined as described by [@B2] and [@B41].

The thermal stability of enzyme was examined after preincubation of the enzyme at 50-80 °C using 0.1 M phosphate buffer (pH 8.0) for different time (10-90 min). The relative activity was determined after the incubation of reaction mixture at 37 °C for 30 min. The thermal inactivation rate (Kr min) was calculated by the first-order kinetic model ([@B53]); Ln(A~t~/A~o~) k~t~T, where A~o~ and A~t~ are the specific activity zero and t time. T1/2 was calculated from the linear equation for each temperature. The Tm was calculated from the linear equation of different preincubation temperature at 60 min.

Stability of L-glutaminase was examined after preincubation of the enzyme for 2 h at pH from 4.0-11.0. Acetate (0.2 M), phosphate (0.2 M) and glycine-NaOH buffers were used to covering pH range (4-5), (6-8) and (9-11) respectively. After adding glutamine (40 mM) the reaction mixture was incubated at 37 °C for 30 min. The activity of the enzyme was determined for each pH.

To assay the metal ions effect, the purified enzyme was pre-incubated with each metal ion separately for 30 min before adding glutamine (40 mM). The enzyme relative activity was determined immediately after incubation at 37 °C for 30 min.

The kinetic parameters of L-glutaminase as Vmax, Km and Kcat were estimated using different concentrations of glutamine, asparagine and aspartic acid, separately (10-100 mM). Michaelis-Mentel constant (Km) and maximum velocity (Vmax) were calculated from Lineweaver-Burk plot. Catalytic efficiency (Kcat) was expressed by the specific activity per mol enzyme.

Cytotoxicity of L- glutaminase
------------------------------

Cytotoxic effect of the L-glutaminase was evaluated using 5 New Zealand rabbits as experimental group and one rabbit as control. Experimental group were injected intravenous with 1 mL of L-glutaminase (132.2 U/mg protein/1.5 ± 0.1 kg) every 5 days for two weeks. After the two weeks, blood samples were collected 10; 25; 40 and 50 day of the last injection. Plasma were collected and stored at -20 °C. RBC, WBC, platelets, hemoglobin ALT, AST, GGT, total protein, albumin, cholesterol, glucose and creatinine were determined as described by [@B6] and [@B35]. Hemolytic activity of the purified L-glutaminase was evaluated using a blood agar assay ([@B48]).

Histopathological examination
-----------------------------

Histological examination for the experimental group and control was carried out on liver and kidney, 50 days of the last injection, according to [@B38].

Anticancer efficiency
---------------------

Anticancer efficiency of L-glutaminase as antitumor was measured against: Human hepatocarcinoma cell line (HepG2); Human breast adenocarcinoma cell line (MCF-7); human colorectal carcinoma cells (HCT-116); Human cervical carcinoma cell line (HeLa) and Raw murine macrophage cells (RAW 264.7. MTT Cell Viability Assay was used as described by [@B13]. (% Cell viability = O.D of treated cells / O.D of control cells X 100. The five human cell lines were purchased from ATCC, USA). The efficiency of L-glutaminase was determined using sigmoidal dose response curve-fitting models (Graphpad Prizm Software, version 3).

Statistical Analyses
--------------------

All statistical analyses were carried out using SPSS ver. 11 on pc i5

Results and Discussion
======================

Identification of *S. canarius* FR strain
-----------------------------------------

The present study showed that, the strain is *S. canarius* FR used (after it has been identified by studying their morphological and biochemical characterization). PCR amplification of 16S rDNA gene confirmed the identity (98%) of *S. canarius* FR. The partial nucleotide sequence of amplified gene was submitted in GenBank (<http://www.ncbi.nlm.nih.gov/GenBank/update.htm>) under accession number KC748492. The results derived from the sequence analysis of the 16S rDNA gene show a G + C content of 58.9 mol % which is in good agreement with the data published for *Streptomyces* by [@B16]. The tested strain was characterized by formation of a pink zone around colonies using MGA medium due to breakdown of amide bond in L-glutamine and ammonia liberation ([@B34]).

Optimization of L-glutaminase production
----------------------------------------

The submerged fermentation method for producing L-glutaminase was showed that, the L-glutaminase produced, is in its optimum phase (at 30 °C for 5 days and pH 7.5 under shaking condition at 120 rpm) (Data was not shown). [@B11] and [@B39] stated that submerged fermentation was the routinely used methods for L-glutaminase production from various microorganisms. The result obtained by [@B18] is in the agreement with present study. They showed that production of L-glutaminase from *Streptomyces* sp. SBU1 was at 30 °C after 96 h of incubation and initial pH 9.0. [@B3] stated that, the optimum conditions for marine *Streptomyces olivochromogenes* L-glutaminase production were determined at pH 7, temperature 30 °C and 3.5% salinity for 5 days under shaking condition at 120 rpm. [@B10] reported that strain of actinomycetes gave maximum production at pH 7, temperature 30 °C, time 96 h and salinity 3.5%. On the other hands, the optimum conditions (pH and Temperature) for L-glutaminase family is varied from one member to another [@B50] studied one of glutaminase family he found that, the maximum production of L-asparaginase from *Pseudonocardia endophytica* VUK-10 was found in the culture medium with pH 8 and temperature 30 °C incubated for four days. Moreover, [@B46] stated that the response surface methodology predicted that a production containing Temperature 36.31 C, pH 7.34, Time 67.63 h, Galactose 40.20 g/L and L-glutamine 19.09 g/L to be optimum for the production of *Serratia marcescens* L-Glutaminase. [@B17] revealed that the maximum yield of *Vibrio azureus* L-glutaminase production (247 U/mL) was achieved in a seawater based medium at pH 8, 37 °C, 1% inoculum concentration and 2% glutamine concentration for 24 h.

Purification of L-glutaminase
-----------------------------

L-glutaminase was purified from 5 days *S. canarius* culture to assess their yield and purity. The crude L-glutaminase was undergoes fractional precipitation by salting out (50-80% ammonium sulfate). The enzyme overall purification profile from *S. canarius* culture was summarized in [Table 1](#t1){ref-type="table"}. The crude extract contained 23.0 mg of protein and showed a total glutaminase activity 170 units with specific activity of 7.4 U/mg protein. At all purification steps, the specific activity increased compared to crude. The maximum specific activity 132.2 IU/mg protein with a yield of 28% was attained after Sephadex G100 purification. The partial purified was increased more than 17 fold compared with crude. These results were in the agreement with that reviewed by [@B27]. Also, [@B19] stated that *Bacillus* sp. LKG-01 (MTCC 10401) L-glutaminase activity was purified 49-fold from cell-free extract with 25% recovery with specific activity 584.2 U/mg protein after gel filtration. On the other hand, [@B12] recorded that an intracellular L-glutaminase from *Penicillium brevicompactum* NRC829 was purified to homogeneity (162.75 fold) with an apparent molecular mass of 71 kDa. So the method used in the present study proved to be a good method in producing and purification of L-glutaminase.

###### Summary of purification steps of *Streptomyces canarius* L- glutaminase.

  Purification steps   Enzyme activity (U)   Total protein (mg)   Specific activity (U/mg protein)   Purification fold   Yield (%)
  -------------------- --------------------- -------------------- ---------------------------------- ------------------- -----------
  Crude extract        170                   23                   7.4                                1                   100
  70% Amm. Sulph.ppt   145                   17                   8.5                                1.2                 85
  DEAE-Cellulose       95                    0.77                 123.4                              16.7                56
  Sephadex G100        47.6                  0.36                 132.2                              17.9                28

Determination of molecular weight for enzyme
--------------------------------------------

The molecular homogeneity of the purified L-glutaminase from fermentation condition, as well as their purification steps were evaluated by SDS-PAGE. Single band at 44 kDa was appeared after final purification step (Column Sephadex G~100~) ([Figure 1](#f1){ref-type="fig"}). Similarly, the molecular mass of the native enzyme from *Stenotrophomonas maltophilia* NYW-81 was estimated to be 41 kDa by gel filtration ([@B51]). And, [@B44] revealed that L-glutaminase extracellularly produced by *Bacillus cereus* MTCC 1305 was purified to apparent homogeneity with a fine band. The molecular weight of native enzyme and its subunit were found to be approximately 140 and 35 kDa, respectively, which indicates its homotetrameric nature.

![SDS- PAGE of purified L-glutaminase from *S. canarius*. Lane M (marker protein), Lane E, the purified enzyme.](1678-4405-bjm-46-04-0957-gf01){#f1}

Biochemical properties of the purified L-glutaminase
----------------------------------------------------

### Optimal pH and pH stability

The L-glutaminase maintained its activity over a range of pH 5.0 −9 with optimum at pH 8.0 ([Figure 2 A](#f2){ref-type="fig"}). The activity significantly decreased at both low and high pH values. The pH stability of the L-glutaminase also showed a similar trend, the enzyme was stable at wide range pH 5.0-11.0 with being most stable at pH 7.0-9.0. Practically, at acidic pH values a higher rate of enzyme inactivation was appeared, comparing to alkaline side, assuming the enzyme basic identity. The negative effect on enzyme activity at lower and higher pH values, suggesting the effect on ionization state of enzyme, modifying the enzyme surface charge, dissociation of subunits/ coenzyme, consequently disrupt its binding with substrate. Consistently, the activity of L-glutaminase from *S. canarius* showed alkaline optimum pH 7-8, this neutral pH stability of enzyme, being a favored criterion for enzyme action in vivo. Similarly, *Streptomyces gulbargensis* L-asparaginase was more stable at the alkaline pH than at the acidic one ([@B2]; [@B19]).

![Characterization of *S. canarius* L-glutaminase. (A) pH value and pH stability profile. The enzyme was preincubated for 2 h at various pHs (4.0 −11.0), then measuring the residual deaminating activity; (B) The optimal temperature for activity was assessed by measuring the enzyme activity at different temperatures between 25 and 50 °C; (C) Thermal stability profile. After incubation of enzyme in different temperature (50-80 °C) at various periods (10-90 min), the residual activity was determined by the standard assay method; (D) Thermal inactivation profile. Tm is temperature degree at which the enzyme retains half of its initial activity at 60 min. (E) Different NaCl concentrations from 0-25%; (F) Km values (Lineweaver-Burk plot) were calculated by fitting the 1 / S of substrate *vs.* the 1 / activity of the enzyme. (1) L-aspartic acid y = 7.4538x + 1.3854; (2) L-asparagine y = 3.4933x + 0.4514; (3) L-glutamine y = 3.7046x + 0.5076.](1678-4405-bjm-46-04-0957-gf02){#f2}

### Optimal temperature and thermal stability

The optimum temperature for the L-glutaminase activity was determined by incubation of the reaction mixture at various degrees (25-50 °C) using L-glutamine as substrate in 0.1 M potassium phosphate buffer (pH 8.0). The highest enzyme specific activity (53.3 U/mg protein) was obtained at 40 °C. Above and below this temperature the enzyme activity decreased ([Figure 2 B](#f2){ref-type="fig"}). Regarding to thermal stability the enzyme had a catalytically thermal stability below 60 °C, with a slightly decreasing in its activity at 70 °C, while completely lost its activity at 80 °C ([Figure 2 C](#f2){ref-type="fig"}). The enzyme half-life times (T~1/2~) was 45.7, 38.8, 29.3 and 17.3 min at 50, 60, 70 and 80 °C, respectively. Also, the Tm of enzyme was 57.5 °C, assuming the retaining of about 50% of its initial activity by heating for 60 min ([Figure 2 D](#f2){ref-type="fig"}). Theoretically, thermal inactivation rates (Kr) are 0.0184, 0.0227, 0.0544 and 0.0449 S^-1^ at 50, 60, 70 and 80°C, suggesting the dissociation of co-enzyme or denaturation of subunits by heating per unit time. These results were in consistent with those reported for [@B2] and [@B19]. Also, [@B44] recorded that the purified L-glutaminase enzyme produced by *Bacillus cereus* MTCC 1305 showed maximum activity at optimum pH 7.5 and temperature 35 °C. The enzyme retained stability up to 50 and 20% even after treatment at 50 and 55 °C, respectively, for 30 min. Furthermore, [@B12] recorded that the purified *Penicillium brevicompactum* L-glutaminase showed its maximal activity against L-glutamine when incubated at pH 8.5 at 50 °C for 30 min indicating the thermo-stability nature of this enzyme.

Salt tolerance of *S. canarius* L-glutaminase
---------------------------------------------

The results represented in [Figure (2 E)](#f2){ref-type="fig"} showed that, tolerance in glutaminase activity was observed by increasing the NaCl concentration up to 25%. This is a good tolerance value. Similarly, [@B51] observed that the L-glutaminase produced from actinomycetes has a good salt tolerance.

Substrate specificity and kinetic properties of *S. canarius* L-glutaminase
---------------------------------------------------------------------------

The kinetic parameters for L-glutaminase towards substrates were determined from the Lineweaver-Burk Plot ([Figure 2 F](#f2){ref-type="fig"} and [Table 2](#t2){ref-type="table"}). The enzyme had relative high affinity and catalytic activity for L-glutamine (Km 0.129 mM, Vmax 2.02 U/mg/min), followed by L-asparagine (Km 0.137 mM, Vmax 1.75 U/mg/min) and low affinity to L-aspartic acid (Km 5.38 mM, Vmax 0.68 U/mg/min). Also, the highest catalytic efficiency (Kcat turnover number) for the enzyme was assessed for L-glutamine (0.75×10^-3^ s-1) followed by L-asparagine (0.68×10^-3^ s-1) and L-aspartic acid (0.25×10^-3^ s-1). The high affinity of *S. canarius* L-glutaminase to L-glutamine as substrate was detected previously by [@B43] and [@B19] for *Streptomyces radiopugnans* MS1 and *Pseudomonas* sp.BTMS-51, respectively. Also, [@B44] revealed that the substrate specificity test of *Bacillus cereus* MTCC 1305 L-glutaminase showed its specificity for L-glutamine. Moreover, the small Km (0.129 mmol) of the tested *S. canarius* L-glutaminase indicated high affinity of the enzyme to glutamine meaning that the rate will approach Vmax more quickly ([@B25]). Also, [@B12] recorded that the highest activity of *Penicillium brevicompactum* L-glutaminase was reported towards its natural substrate, L-glutamine, with an apparent Km value of 1.66 mM.

###### Kinetics of *S. canarius* L- glutaminase.

  Substrates (mM)   Km (mmol ^-1^)   Vmax (U mg^-1^ protein min^-1^)   Kcat (s^-1^)
  ----------------- ---------------- --------------------------------- --------------
  L- glutamine      0.129            2.02                              0.75×10^-3^
  L- asparagines    0.137            1.83                              0.68×10^-3^
  Aspartic acid     5.38             0.68                              0.25×10^-3^

Influence of metal ions on L-glutaminase activity
-------------------------------------------------

The impact of various inhibitors and activators on catalytic potency of the prepared L-glutaminase was evaluated by pre incubation of the enzyme with each compound for 30 min without substrate. Results in [Table 3](#t3){ref-type="table"} showed that, Ca^+2^, Ba^+2^, Fe^+3^, Zn^+2^, Cu^+^, Hg^+2^ and Cd^+2^ considered to be inhibitor. On the other hand, Mn^+2^, Na^+^ and Co^+2^ were shown to be activator. These results were in agreement with [@B43] for *S. radiopugnans* MS1 L-asparaginase. Also, [@B44] reported that monovalent cations (Na(+), K(+)) and phosphate ion activated the *B. cereus* MTCC 1305 L-glutaminase activity, while divalent cations (Mg(2+), Mn(2+), Zn(2+), Pb(2+), Ca(2+), Co(2+), Hg(2+), Cd(2+), Cu(2+)) inhibited its activity.

###### Effect of inhibitors and activators on L- glutaminase activity.

  Metal ions (5 mM)   Relative activity (%)
  ------------------- -----------------------
  None (control)      100.67 abc ±0.15
  Ca^+2^              75.33 cd± 0.76
  Na^+2^              105.00 ab **±** 0.50
  Ba^+2^              56.70 d**±** 5.29
  Mg^+2^              81.33 bc ±60.48
  Hg^+2^              20.00 e ±0.50
  Co^+2^              122.00 a**±** 0.50
  Fe^+3^              53.00 d±0.87
  Mn^+2^              125.00 a**±** 0.50
  Cu^+2^              50.00 d±0.50
  Zn^+2^              87.00 bc **±** 0.92
  Cd^+2^              17.00 e ±0.50
  l.s.d               27.49
  F                   12.669
  Sig.                .000

Cytotoxicity effect of L-glutaminase
------------------------------------

The cytotoxicity effect of purified *S. canarius* L-glutaminase was explored based on the hematological and blood chemistry pictures for the New Zealand rabbits ([Table 4](#t4){ref-type="table"}). From the biochemical profiles, generally, there is no observed effect on liver, renal functions, glucose, lipids and other electrolytes, with slight inducing effect on the activity of ALT, AST and level of Random S. Glucose. Depending on these results, the L-glutaminase had relatively no negative effect on liver functions, where AST and ALT was the most potential indicator for liver dysfunction, this in the agreement with that obtained by [@B33].

###### Hematological and biochemical parameters of rabbits in response to *S. canarius* L-glutaminase.

  Parameters                 Control (at zero time)   After 10 days   After 25 days   After 40 days   After 50 days                                                                              
  -------------------------- ------------------------ --------------- --------------- --------------- --------------- -------- ------------- -------- -------- -------------- -------- --------- ------------
  Serum Bilirubin: Total     0.81                     0.77            0.65            6.29\*          0.74            0.63     12.85\*\*     0.75     0.66     9.0\*          0.72     0.64      2.28 n.s
  Direct                     0.22                     0.19            0.14            4.330           0.20            0.64     -.936         0.21     0.17     11.000         0.20     0.17      2.598 n.s
  Serum Proteins: Total      4.50                     4.64            4.81            11.930-\*\*     4.58            4.35     39.837\*\*    4.94     5.09     -8.660\*       4.90     4.81      3.118 n.s
  Albumin                    3.55                     3.58            2.88            2.177 n.s       3.50            3.18     19.4\*\*      3.52     3.48     1.857 n.s      3.45     3.38      2.291 n.s
  Globulins                  3.12                     3.17            4.10            -46.50\*\*      3.32            3.45     -8.51\*       3.34     3.37     -2.219 n.s     3.38     3.34291   1.571 n.s
  S. Alk. Phosphatase        239                      243.00          254.67          -4.27\*         245.33          274.00   43.00-\*\*    247.33   251.67   3.606-n.s      245.00   249.00    -3.464 n.s
  GGT                        11                       11.67           15.00           -4.0n.s         13.17           14.50    -8.0\*        12.63    13.00    -.78 n.s       12.10    12.50     -2.62 n.s
  S.GOT (AST)                22                       29.00           43.00           \*\* 23.89-     32.33           41.00    -8.549\*      31.00    39.00    \*\* 10.474-   30.00    34.00     -2.619n.s
  S.GPT (ALT)                66                       68.00           80.67           -38.0\*\*       66.00           69.00    -1.44n.s      64.00    67.00    -1.29n.s       63.00    65.00     -.756n.s
  Serum cholesterol: Total   45                       53.00           56.00           -2.59n.s        49.00           46.00    1.964n.s      47.00    47.00    .000n.s        52.00    51.00     .577n.s
  Blood Urea                 0.75                     0.80            1.05            -21.65\*        0.88            1.03     0.78 n.s      0.93     0.99     2.268-n.s      0.90     0.99      -7.794\*
  S. Creatine                135                      138.00          125.33          4.865\*         140.00          134.00   2.598n.s      145.00   138.00   2.782 n.s      142.00   140.00    .866n.s
  Random S. Glucose          93                       100.33          115.00          -15.81\*\*      107.00          118.00   -19.053\*\*   100.00   106.00   10.392\*\*     104.00   102.00    1.0n.s
  Red Blood cells (RBC)      6.12                     6.29            5.00            4.338\*\*       6.37            5.93     44.00\*\*     6.53     6.17     23.568\*\*     6.50     6.47      1.299n.s
  Hemoglobin)                11.7                     11.33           10.00           3.941 n.s       11.40           11.20    1.23 n. s     11.70    11.00    2.646 n.s      11.90    11.20     6.062\*
  White blood cells (WBC)    9.8                      9.50            8.90            4.32\*          9.90            7.60     9.959\*       9.80     9.80     .000 n.s       9.70     9.00      1.732n.s
  Platelets                  382                      379.00          360.00          11.332\*\*      378.00          373.33   1.257n.s      376.33   374.67   1.7814n.s      383.00   372.67    2.23n.s

\*, \*\* and NS indicate p \< 0.05, p \< 0.01 and not significant, respectively.

Five New Zealand rabbits were i.v. injected by 1 mL of three successive doses of *S. canarius* L- glutaminase (132.2 U/mg protein/1.5 ±0.1 kg) during two weeks. Blood samples were collected after 10,25,40 and 50 day of the last injection. Control sera (zero time) without enzyme injection were used.

Also, the cellular toxicity of the purified *S. canarius* L-glutaminase was evaluated by estimation of the degree of platelet aggregations and hemolytic activity as described by [@B52]. All the hematological parameters ([Table 4](#t4){ref-type="table"}) were in normal range along the experimented period, however, the red blood cells, hemoglobin, white blood cells and the platelets slightly decreased within normal range after 10 days of L-glutaminase injection. The L-glutaminase displayed no hemolytic activity to human blood ([Figure 3](#f3){ref-type="fig"}). Platelet aggregation and hemolytic activity are the most relevant biochemical assays ([@B33]). The lack of ability to aggregate human platelets and lyses of human RBCs are unique supportive criteria from therapeutic point of view. Similar results approved the non cytotoxicity of microbial glutaminase ([@B5]).

![Hemolytic activities of *Strepromyces canarius* L- glutaminase, 100 μL of purified enzyme (A) and 200 μL purified enzyme (B).](1678-4405-bjm-46-04-0957-gf03){#f3}

Histological studies
--------------------

[Figures (4](#f4){ref-type="fig"} and [5](#f5){ref-type="fig"}) show photomicrograph of liver and kidney section histological of treated and non treated rabbits after 50 days of the last injection. It can be seen from photomicrograph of renal and liver tissues, there is no observed abnormalities in these structure. Since, the kidney showing normal glomeruli surrounded by normal renal tubules lined cubical epithelial cells, whereas in treated tissue showed round distal convoluted tubules lined by cubical epithelium and longitudinal collecting duct lined by columnar epithelium ([Figure 4](#f4){ref-type="fig"}). Photomicrograph of treated rabbit liver showing variable sized central veins surrounded by cords and rows of hepatocytes, comparing with negative control ([Figure 5](#f5){ref-type="fig"}). These results were in similarity with that obtained by [@B5] and [@B38].

![Photomicrograph (at Hematoxylin and Eosin X 150 and X200) of renal section of, (A) negative control showing normal glomeruli (↑) surrounded by normal renal tubules lined cubical epithelial cells. (B) treated with *S. canarius* L-glutaminase showing round distal convoluted tubules (↑) lined by cubical epithelium and longitudinal collecting duct lined by columnar epithelium.](1678-4405-bjm-46-04-0957-gf04){#f4}

![Photomicrograph (at H & E X 150 and X200) of liver section of (C) negative control showing normal architecture formed of central vein (↑) and portal tract (ñ) surrounded by cords and rows of normal hepatocytes. (D) Treated with *S. canarius* L-glutaminase showing variable sized central veins (↑) surrounded by cords and rows of hepatocytes.](1678-4405-bjm-46-04-0957-gf05){#f5}

Anticancer efficiency *in vitro*
--------------------------------

Using MTT assay in the present investigation, the effect of the purified enzyme on the growth of Hep-G2, MCF7, HCT-116, HeLa and RAW 264.7 cells were studied after 48 h of incubation. As shown in [Figure (6)](#f6){ref-type="fig"}, the tested enzyme had a high efficiency against Hep-G2 cell (IC~50~, 6.8 μg/mL) and HeLa cells (IC~50~, 8.3 μg/mL), while the growth of MCF-7 cells was not affect by the treatment. In the other hand, the treatment of HCT-116 and RAW 264.7 cells with the tested enzyme indicated that there was a moderate cytotoxic effect as concluded from their high IC~50~ calculated values: 64.7 μg/mL and 59.3 μg/mL, respectively, compared with the known anticancer drug paclitaxel, which its IC~50~ values for these cell lines ranged from 0.5-1.2 μg/mL. Similarly, [@B9] showed that the purified L-asparaginase from *Erwinia carotovora* MTCC 1428 used for killing of Hep-2C cell line. Also, *E. carotovora* MTCC 1428 asparaginase was showed better *in vitro* toxicity on Hep-2C cell lines (84% survival) in comparison to commercial L-asparaginase preparation (90% survival) obtained from *E. coli*. Also, [@B44] reported that the gradual inhibition in growth of hepatocellular carcinoma (Hep-G2) cell lines was found with IC~50~ value of 82.27 μg/mL in the presence of different doses of L-glutaminase (10-100 μg/mL). Moreover, [@B12] recorded that the purified enzyme produced by *Penicillium brevicompactum* was inhibited the growth of human cell line hepatocellular carcinoma (Hep-G2), with IC~50~ value of 63.3 ug/mL. Meanwhile, [@B30] indicated a crucial role of *Aspergillus flavus* KUGF009 L-glutaminase in breast cancer (MCF7). Furthermore, [@B37] found that L-glutaminase from *Pseudomonas* sp. 7A is administered to inhibit HIV replication in infected cells. The enzyme brings about inhibition of tumor (melanoma) and DNA biosynthesis in affected cells. Glutaminase and asparaginase enzymes have produced prolonged remissions of certain experiment tumors ([@B54]). During treatment, plasma glutamine and asparagines are depleted. The degree of amino acid depletion depends on the kinetic properties of the enzymes, its biological half life in the animal, and the rate of input of the amino acid into circulation ([@B54]).

![Cytotoxic effect of *S. canarius* L-glutaminase on tumor cell lines using MTT assay (n = 4), HCT-116 (A), MCF-7 (B), HepG2 (C), HeLa (D) and RAW 264.7 (E). Cells exposed to different concentrations of the drug for 48 hours. All data are expressed as the mean value of cell viability (% of control) ± S.E.s](1678-4405-bjm-46-04-0957-gf06){#f6}

In conclusion, *S. canarius* (KC460654) had remarkable capacity to produce L-glutaminase. The purified enzyme showed a unique specificity to glutamine, broad pH stability, and high thermal stability. Also, the purified enzyme is being promising candidate for application as antitumor agent in the future work.
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